OK Biotech Co., Ltd. (TPE:4155)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
13.95
0.00 (0.00%)
At close: Mar 5, 2026
Market Cap1.97B -34.9%
Revenue (ttm)1.64B +7.5%
Net Income68.75M +196.9%
EPS0.47 +198.5%
Shares Out141.38M
PE Ratio29.54
Forward PEn/a
Dividend0.30 (2.15%)
Ex-Dividend DateJul 4, 2025
Volume144,220
Average Volume150,198
Open14.00
Previous Close13.95
Day's Range13.90 - 14.05
52-Week Range13.80 - 21.85
Beta0.15
RSI33.08
Earnings DateMar 26, 2026

About OK Biotech

OK Biotech Co., Ltd. develops, manufactures, markets, and sells blood glucose monitoring systems and homecare healthcare devices in Taiwan and internationally. It also offers OTC hearing aids, multi-frequency therapy devices, and factory setup solutions. The company was founded in 2004 and is based in Hsinchu City, Taiwan. [Read more]

Sector Healthcare
Founded 2004
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4155
Full Company Profile

Financial Performance

In 2024, OK Biotech's revenue was 1.67 billion, an increase of 40.11% compared to the previous year's 1.19 billion. Earnings were 93.98 million, an increase of 3087.75%.

Financial Statements